Pathogenic variants in genes encoding core telomerase components (TERT (Telomerase Reverse Transcriptase) and TERC (Telomerase RNA Component)), or genes involved in telomere maintenance and function, have been identified in 60–70% of patients with clinical features of DC. The gene discussed is TERC; the disease is dyskeratosis congenita.